WaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company's ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company's SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company's SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Symbol: NASDAQ:WGBS
- CUSIP: N/A
- Web: www.wafergen.com
- 50 Day Moving Avg: $5.96
- 200 Day Moving Avg: $2.96
- 52 Week Range: $0.50 - $7.00
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -3.73
- P/E Growth: 0.00
- Net Margins: -225.65%
- Return on Equity: -221.83%
- Return on Assets: -95.23%
- Debt-to-Equity Ratio: 1.90%
- Current Ratio: 1.82%
- Quick Ratio: 1.53%
- Average Volume: 59,700 shs.
- Beta: 1.29
Frequently Asked Questions for WaferGen Bio-systems (NASDAQ:WGBS)
What is WaferGen Bio-systems' stock symbol?
WaferGen Bio-systems trades on the NASDAQ under the ticker symbol "WGBS."
How were WaferGen Bio-systems' earnings last quarter?
WaferGen Bio-systems, Inc. (NASDAQ:WGBS) posted its quarterly earnings data on Tuesday, August, 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by $0.08. The company had revenue of $2.50 million for the quarter, compared to the consensus estimate of $2.60 million. WaferGen Bio-systems had a negative return on equity of 221.83% and a negative net margin of 225.65%. View WaferGen Bio-systems' Earnings History.
Who are some of WaferGen Bio-systems' key competitors?
Some companies that are related to WaferGen Bio-systems include Thermo Fisher Scientific (TMO), Agilent Technologies (A), Quintiles IMS Holdings (Q), Quest Diagnostics (DGX), Laboratory Corp. of America Holdings (LH), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), DexCom (DXCM), Icon Plc (ICLR), PRA Health Sciences (PRAH), Charles River Laboratories Intl. (CRL), VWR Corp (VWR), Bruker (BRKR), Alere (ALR), PAREXEL International (PRXL), EXACT Sciences (EXAS), WuXi PharmaTech (Cayman) (WX) and Accelerate Diagnostics (AXDX).
How do I buy WaferGen Bio-systems stock?
Shares of WaferGen Bio-systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of WaferGen Bio-systems stock cost?
One share of WaferGen Bio-systems stock can currently be purchased for approximately $6.90.
Consensus Ratings for WaferGen Bio-systems (NASDAQ:WGBS) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for WaferGen Bio-systems (NASDAQ:WGBS)
(Data available from 5/25/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|3/14/2016||Ladenburg Thalmann Financial Services||Lower Price Target||Buy||$6.00 -> $5.00||N/A|
|9/17/2015||Brean Capital||Reiterated Rating||Buy||$11.00||N/A|
Earnings History for WaferGen Bio-systems (NASDAQ:WGBS)Earnings History by Quarter for WaferGen Bio-systems (NASDAQ:WGBS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/8/2016||Q3||($0.13)||($0.19)||$2.50 million||$2.40 million||View||Listen|
|8/9/2016||Q216||($0.18)||($0.26)||$2.60 million||$2.50 million||View||N/A|
|11/10/2015||Q315||($0.61)||($0.61)||$2.00 million||$2.00 million||View||N/A|
|8/5/2015||Q215||($0.65)||($0.67)||$2.10 million||$1.60 million||View||N/A|
Earnings Estimates for WaferGen Bio-systems (NASDAQ:WGBS)
Current Year EPS Consensus Estimate: $-4.30 EPS
Next Year EPS Consensus Estimate: $-1.85 EPS
Dividend History for WaferGen Bio-systems (NASDAQ:WGBS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for WaferGen Bio-systems (NASDAQ:WGBS)
Insider Ownership Percentage: 5.78%Insider Trades by Quarter for WaferGen Bio-systems (NASDAQ:WGBS)
Institutional Ownership Percentage: 49.77%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/24/2015||Awm Investment Company, Inc.||Major Shareholder||Sell||505,282||$2.10||$1,061,092.20|| |
|9/22/2015||Awm Investment Company, Inc.||Major Shareholder||Sell||492,373||$2.31||$1,137,381.63|| |
Headline Trends for WaferGen Bio-systems (NASDAQ:WGBS)
Latest Headlines for WaferGen Bio-systems (NASDAQ:WGBS)
WaferGen Bio-systems (WGBS) Chart for Thursday, May, 25, 2017